Cochlear Limited (COH)

Index:

ASX 100

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $249.78
  • Currency: Australian Dollars
  • Shares Issued: 57.69m
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 2,373.68 529.23 492.13¢ 61.2 0.2 +392% 345.96¢ 0.0%
30-Jun-26 2,631.23 606.97 564.54¢ 53.3 3.6 +15% 388.95¢ 0.0%
30-Jun-27 2,914.37 690.26 641.22¢ 46.9 3.5 +14% 447.67¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
30-Jun-25 $41.15 7.31
30-Jun-26 $45.61 6.60
30-Jun-27 $50.52 5.96

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
30-Jun-2026 2,631 2,631 n/a 2,657 2,679 2,700
30-Jun-2027 2,914 2,914 n/a 2,922 2,924 n/a
 
Earnings
30-Jun-2026 564.54¢ 566.16¢ n/a 579.70¢ 582.94¢ 625.09¢
30-Jun-2027 641.22¢ 645.71¢ n/a 656.40¢ 664.17¢ n/a
 
Dividend
30-Jun-2026 388.95¢ 388.95¢ n/a 398.13¢ 408.51¢ 436.81¢
30-Jun-2027 447.67¢ 447.67¢ n/a 455.82¢ 466.40¢ n/a
 
Recommendations
Strong Buy 3 0 2 2 0 0
Buy 3 0 3 3 1 1
Neutral 7 0 8 8 8 6
Sell 2 0 2 2 3 5
Strong Sell 0 0 0 0 2 2
No. of Brokers 15 0 15 15 14 14
 
Average Rec 6.17 n/a 5.83 5.83 3.93 3.57

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

COH Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $249.78
Shares Issued 57.69m

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 7
Sell 2
Strong Sell 0
Total 15
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page